Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Globus Medical Inc. Class A Common Stock (GMED) vs YieldMax TSLA Option Income Strategy ETF (TSLY) Price & Performance

Globus Medical Inc. Class A Common StockTrade
YieldMax TSLA Option Income Strategy ETFTrade

Price performance (Past 24H)

Key statistics

Globus Medical Inc. Class A Common Stock vs YieldMax TSLA Option Income Strategy ETF — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while YieldMax TSLA Option Income Strategy ETF trades at $21.32 (market cap $675.95M). The key difference: Globus Medical Inc. Class A Common Stock is far larger — about 15.2× YieldMax TSLA Option Income Strategy ETF's market cap, and Globus Medical Inc. Class A Common Stock is trading nearer its 52-week high, YieldMax TSLA Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and YieldMax TSLA Option Income Strategy ETF for 45 Days on average.

GMEDTSLY
Market Cap
$10.25B$675.95M
Volume
1,108,124216,837
Sector
HealthIncome / Options Overlay
52-Week High
$96.82$43.35
52-Week Low
$58.33$20.49
Typical Hold Time
0 Days45 Days
Enterprise Value
$9.76B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Globus Medical Inc. Class A Common Stock

Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.

GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.

YieldMax TSLA Option Income Strategy ETF

TSLY trades at $22.11, down 0.58% with a bearish technical signal from moving averages. The ETF maintains consistent weekly dividend distributions averaging $0.21-0.26, though recent news highlights concerns about underperformance relative to Tesla's stock gains. Technical indicators show neutral oscillators with key support at $22 and resistance at $23.

The outlook remains cautious as TSLY faces structural challenges capturing Tesla's upside while providing income. Investors should weigh the high dividend yield against potential capital erosion during Tesla rallies. Key risks include volatility regime changes and the ETF's option strategy limitations in strong bull markets.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GMED
100% Buy0% Sell
Avg holding period · 0 Days
TSLY
59% Buy41% Sell
Avg holding period · 45 Days

Top news

Latest headlines on both assets

About Globus Medical Inc. Class A Common Stock

Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.

Read more on GMED →

About YieldMax TSLA Option Income Strategy ETF

TSLY is an actively managed ETF that seeks to provide high monthly income by employing a synthetic covered call strategy on Tesla, Inc. (TSLA). It does not own Tesla stock directly; instead, it uses a combination of call and put options to simulate long exposure while simultaneously selling call options to collect premiums. It is designed for income-focused investors who are willing to trade TSLA's potential upside for immediate, aggressive yield.

Read more on TSLY →